Literature DB >> 28129715

Serum anti-Müllerian hormone levels decrease after endometriosis surgery.

Young-Joo Kim1, Sun-Wha Cha1, Hye-Ok Kim1.   

Abstract

The purpose of this study was to evaluate and compare the post-operative decline in serum AMH levels in patients with endometriosis and other benign cysts. This study also attempts to clarify the factors of endometriosis that may influence the AMH level. A total of 75 were recruited prospectively between 2011 and 2012. Fifty-nine patients had endometriosis, while the other 16 had another kind of benign ovarian cyst. In the endometriosis group, the AMH level decreased significantly from pre- to postoperatively (4.3 ± 0.4 vs. 2.8 ± 0.2, p<.001). This significant decrement in AMH levels was present in the endometriosis group regardless of multiplicity (p=.028 vs. p<.001) and bilaterality (p=.003 vs. p<.001). The stage III-IV endometriosis group also demonstrated a significant decrease (p<.001). Laparoscopic ovarian cystectomy in patients with endometriosis may cause a decrease in serum AMH levels. We suggest that preoperative and postoperative AMH levels should be evaluated in reproductive-aged women with endometriosis for their future fertility.

Entities:  

Keywords:  Anti-Müllerian hormone; cyst; endometriosis; laparoscopy; ovarian reserve

Mesh:

Substances:

Year:  2017        PMID: 28129715     DOI: 10.1080/01443615.2016.1239071

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  9 in total

1.  Endometriosis-associated infertility: GDF-9, AMH, and AMHR2 genes polymorphisms.

Authors:  Emily De Conto; Úrsula Matte; João Paolo Bilibio; Vanessa Krebs Genro; Carlos Augusto Souza; Delva Pereira Leão; João Sabino Cunha-Filho
Journal:  J Assist Reprod Genet       Date:  2017-08-22       Impact factor: 3.412

2.  Relationship between bone mineral density and ovarian function and thyroid function in perimenopausal women with endometriosis: a prospective study.

Authors:  Mari Uehara; Osamu Wada-Hiraike; Mana Hirano; Kaori Koga; Noriko Yoshimura; Sakae Tanaka; Yutaka Osuga
Journal:  BMC Womens Health       Date:  2022-04-27       Impact factor: 2.742

3.  Efficacy of ablation and sclerotherapy for the management of ovarian endometrioma: A narrative review.

Authors:  Byung Chul Jee
Journal:  Clin Exp Reprod Med       Date:  2022-05-04

4.  Endometriosis and ART: A prior history of surgery for OMA is associated with a poor ovarian response to hyperstimulation.

Authors:  Mathilde Bourdon; Jade Raad; Yaniv Dahan; Louis Marcellin; Chloé Maignien; Marc Even; Khaled Pocate-Cheriet; Marie Charlotte Lamau; Pietro Santulli; Charles Chapron
Journal:  PLoS One       Date:  2018-08-20       Impact factor: 3.240

5.  Predictive value of the serum anti-Müllerian level for spontaneous pregnancy in women after endometriosis surgery.

Authors:  Yong Zhou; Chaolu Chen; Changchang Hu; Yuan Wang; Xian Zhang; Ruijin Wu
Journal:  J Int Med Res       Date:  2019-09-26       Impact factor: 1.671

Review 6.  Impact of Surgical Management of Endometrioma on AMH Levels and Pregnancy Rates: A Review of Recent Literature.

Authors:  Ana Sofia Pais; Clara Flagothier; Linda Tebache; Teresa Almeida Santos; Michelle Nisolle
Journal:  J Clin Med       Date:  2021-01-22       Impact factor: 4.241

Review 7.  The Effect of Laparoscopic Endometrioma Surgery on Anti-Müllerian Hormone: A Systematic Review of the Literature and Meta-Analysis.

Authors:  José Moreno-Sepulveda; Carolina Romeral; Geraldine Niño; Assumpció Pérez-Benavente
Journal:  JBRA Assist Reprod       Date:  2022-01-17

8.  Effect of laparoscopic cystectomy on ovarian reserve in patients with ovarian cyst.

Authors:  Ghazal Mansouri; Maryam Safinataj; Armita Shahesmaeili; Leila Allahqoli; Hamid Salehiniya; Ibrahim Alkatout
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-30       Impact factor: 6.055

Review 9.  The role of antimullerian hormone in assessing ovarian damage from chemotherapy, radiotherapy and surgery.

Authors:  Queenie Ho Yan Wong; Richard A Anderson
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2018-12       Impact factor: 3.243

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.